Harrow, Inc. (HROW)
(Delayed Data from NSDQ)
$24.82 USD
-0.03 (-0.12%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $24.82 0.00 (0.00%) 6:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HROW 24.82 -0.03(-0.12%)
Will HROW be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for HROW based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HROW
Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?
VYNE Therapeutics Inc. (VYNE) Reports Q1 Loss, Misses Revenue Estimates
HROW: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Sell Stocks for November 14th
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
Strength Seen in Harrow (HROW): Can Its 17.8% Jump Turn into More Strength?
Other News for HROW
Harrow to Attend 2024 ASRS Annual Meeting
Harrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow Products
Harrow Successfully Manufactures Triesence; Management Credibility Soars
The Best High Yield Bonds Update
Harrow price target raised by $4 at Craig-Hallum, here's why